Inhaled PLGA Particles of Prostaglandin E1 Ameliorate Symptoms and Progression of Pulmonary Hypertension at a Reduced Dosing Frequency-Reference-Cited by-同舟云学术

Inhaled PLGA Particles of Prostaglandin E1 Ameliorate Symptoms and Progression of Pulmonary Hypertension at a Reduced Dosing Frequency

Published:2013-03-26 Issue:5 Volume:10 Page:1655-1667
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Gupta Vivek¹,Gupta Nilesh¹,Shaik Imam H.¹,Mehvar Reza¹,Nozik-Grayck Eva²,McMurtry Ivan F.³,Oka Masahiko³,Komatsu Masanobu⁴,Ahsan Fakhrul¹

Affiliation:

1. Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1300 S Coulter, Amarillo, Texas 79106, United States

2. Department of Pediatrics, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado 80045, United States

3. Departments of Pharmacology and Medicine, The Center for Lung Biology, University of South Alabama, Mobile, Alabama 36688, United States

4. Sanford-Burnham Medical Research Institute at Lake Nona, Orlando, Florida 32827, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp300426u

Reference59 articles.

1. Inhalational Therapy for Pulmonary Arterial Hypertension: Current Status and Future Prospects

2. Primary Pulmonary Hypertension

3. Pulmonary arterial hypertension: New insights and new hope

4. Basic features of hypoxic pulmonary vasoconstriction in mice

5. Alternatives to Lung Transplantation: Treatment of Pulmonary Arterial Hypertension

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications;Journal of Drug Delivery Science and Technology;2023-06

2. Newer insights into the pathobiological and pharmacological basis of the sex disparity in patients with pulmonary arterial hypertension;American Journal of Physiology-Lung Cellular and Molecular Physiology;2021-06-01

3. Bioengineering approach for pulmonary drug delivery;Bioinspired and Biomimetic Materials for Drug Delivery;2021

4. The impact of size and charge on the pulmonary pharmacokinetics and immunological response of the lungs to PLGA nanoparticles after intratracheal administration to rats;Nanomedicine: Nanotechnology, Biology and Medicine;2020-11

5. The Effect of Particle Size and Surface Roughness of Spray-Dried Bosentan Microparticles on Aerodynamic Performance for Dry Powder Inhalation;Pharmaceutics;2020-08-13